5AM Ventures

5AM Ventures

5AM Ventures

Follow us
Alexa global traffic share
Latest investments Show all
$24,000,000
Venture capital (Series G)
RareCyte
$60,000,000
Venture capital (Series B)
Neurogastrx
Team Size
1–10
Employees
Geographical Focus
Past year's investments

5AM Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • RareCyte: Venture capital (Series G) ($24M)
  • Neurogastrx: Venture capital (Series B) ($60M)
  • Kinaset Therapeutics: Venture capital (Series A) ($40M)